Caxton Associates (New York)’s Ambev ABEV Stock Holding History

Caxton Associates (New York)’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-650,000	Closed	-$3.74M	–	141
2015 Q1	$3.74M	Buy	+650,000	New	+$4.04M	0.15%	105
2014 Q3	–	Sell	-1,300,000	Closed	-$9.15M	–	186
2014 Q2	$9.15M	Sell	1,300,000 -260,500	-17%	-$1.92M	0.48%	42
2014 Q1	$11.6M	Buy	+1,560,500	New	+$10.9M	0.71%	31

Other funds holding ABEV

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.8B AUM 25.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

GTP

Global Thematic Partners New York $120M AUM 25.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Caxton Associates (New York)'s ABEV Position: Q2 2015 in Review

Caxton Associates (New York) sold out of Ambev (ABEV) in Q2 2015, closing a stake of 650,000 shares — an estimated $3.74M sold.

Caxton Associates (New York) first reported a position in ABEV in Q1 2014 and held it in 3 quarters. The position peaked at $11.6M in Q1 2014. 303 funds tracked by Wall St. Rank hold ABEV as of Q2 2015.

Caxton Associates (New York) reported no remaining Ambev position as of Q2 2015 after selling out during the quarter.
Caxton Associates (New York) sold 650,000 Ambev shares in Q2 2015, an estimated $3.74M.
Caxton Associates (New York) first reported a position in Ambev in Q1 2014 and held it in 3 quarters.
Caxton Associates (New York)'s Ambev position peaked at $11.6M in Q1 2014.
303 funds tracked by Wall St. Rank held Ambev as of Q2 2015.

Based on Caxton Associates (New York)'s 13F filing for Q2 2015, filed 14 Aug 2015.